David Lewin to Costs and Cost Analysis
This is a "connection" page, showing publications David Lewin has written about Costs and Cost Analysis.
Connection Strength
0.024
-
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party. Lung Cancer. 2012 Sep; 77(3):605-10.
Score: 0.024